"Hemoglobins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements.
| Descriptor ID |
D006454
|
| MeSH Number(s) |
D12.776.124.400 D12.776.422.316.762
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hemoglobins".
Below are MeSH descriptors whose meaning is more specific than "Hemoglobins".
This graph shows the total number of publications written about "Hemoglobins" by people in this website by year, and whether "Hemoglobins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 7 | 7 |
| 1995 | 0 | 5 | 5 |
| 1996 | 0 | 6 | 6 |
| 1997 | 2 | 3 | 5 |
| 1998 | 0 | 2 | 2 |
| 1999 | 4 | 0 | 4 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 3 | 3 |
| 2002 | 4 | 12 | 16 |
| 2003 | 3 | 14 | 17 |
| 2004 | 1 | 6 | 7 |
| 2005 | 4 | 8 | 12 |
| 2006 | 1 | 12 | 13 |
| 2007 | 4 | 6 | 10 |
| 2008 | 3 | 7 | 10 |
| 2009 | 3 | 7 | 10 |
| 2010 | 5 | 10 | 15 |
| 2011 | 3 | 10 | 13 |
| 2012 | 4 | 4 | 8 |
| 2013 | 3 | 14 | 17 |
| 2014 | 8 | 6 | 14 |
| 2015 | 6 | 7 | 13 |
| 2016 | 2 | 6 | 8 |
| 2017 | 2 | 10 | 12 |
| 2018 | 1 | 5 | 6 |
| 2019 | 5 | 8 | 13 |
| 2020 | 3 | 4 | 7 |
| 2021 | 1 | 9 | 10 |
| 2022 | 1 | 9 | 10 |
| 2023 | 0 | 10 | 10 |
| 2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemoglobins" by people in Profiles.
-
Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosis. Blood. 2024 10 24; 144(17):1813-1820.
-
Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial. Lancet Haematol. 2024 Sep; 11(9):e646-e658.
-
Reticulocyte hemoglobin equivalent as a marker to assess iron deficiency: A large pediatric tertiary care hospital study. Int J Lab Hematol. 2024 Feb; 46(1):148-155.
-
Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis. Nephrol Dial Transplant. 2023 09 29; 38(10):2358-2367.
-
Examining Potential Modifiers of Human Skin and Plasma Carotenoid Responses in a Randomized Trial of a Carotenoid-Containing Juice Intervention. J Nutr. 2023 11; 153(11):3287-3294.
-
Market Competition and Anemia Management in the United States Following Dialysis Payment Reform. Med Care. 2023 Nov 01; 61(11):787-795.
-
Initial von Willebrand factor antigen values in adolescent females predict future values. Haemophilia. 2023 Nov; 29(6):1547-1555.
-
Red Blood Cell Conservation and Use in the Cardiovascular Operating Rooms at Ben Taub General Hospital. J Cardiothorac Vasc Anesth. 2023 10; 37(10):1946-1950.
-
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial. Lancet. 2023 07 29; 402(10399):373-385.
-
Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms. Blood. 2023 04 27; 141(17):2127-2140.